In June, Demetrius Albanes, M.D., Nutritional Epidemiology Branch (NEB), spoke on “Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study” for a television interview with the Korean Broadcasting Service.
In June, Blanche P. Alter, M.D., M.P.H., Clinical Genetics Branch (CGB), spoke on inherited bone marrow failure syndromes at Children’s Hospital in Hannover, Germany; the annual German Fanconi Anemia Symposium at University Children’s Hospital in Dusseldorf, Germany; the Institute of Human Genetics at the University of Würzburg in Germany; the University Hospital Münster in Germany; the German Fanconi Anemia Family Meeting in Nottuln, Germany; and the Annual Meeting for Pediatric Aplastic Anemia and Myelodysplastic Syndromes in Nagoya, Japan. Also in June, she gave a presentation on “When and how should the doctor inform the patient/parents about a ‘genetic’ predisposition?” at the Symposium on Genetic Testing and Counseling at St. Luke’s International Hospital in Tokyo, Japan. In June and July, Dr. Alter gave presentations on Fanconi anemia and Diamond-Blackfan anemia at Camp Sunshine family support group meetings in Casco, Maine.
In May, Laura Beane Freeman, Ph.D., and Aaron E. Blair, Ph.D., M.P.H., both of the Occupational and Environmental Epidemiology Branch (OEEB), presented at a meeting on lymphatic and hematopoietic cancer and pesticides sponsored by the Occupational Cancer Research Centre in Toronto, Canada.
In June, Laura Beane Freeman, Ph.D. (OEEB), gave a talk on “Use of 2,4-D and cancer incidence in the Agricultural Health Study” at the annual EPICOH (Scientific Committee on Epidemiology in Occupational Health) meeting in Utrecht, the Netherlands. Melissa Friesen, Ph.D. (OEEB), spoke at the same meeting on “Using hierarchical clustering methods to identify jobs with similar response patterns in a population-based case-control study.”
In June, Amy Berrington de González, D.Phil., Radiation Epidemiology Branch (REB), spoke on “CT scans: Trends in use, doses, and potential cancer risks” at the Nuclear Regulatory Commission Chairman’s Seminar in Bethesda, Maryland.
In April, Aaron E. Blair, Ph.D., M.P.H. (OEEB), Jay H. Lubin, Ph.D., a special volunteer with the Biostatistics Branch (BB), and Debra Silverman, Sc.D., Chief of OEEB, received the Alice Hamilton Award for Occupational Safety and Health from the National Institute for Occupational Safety and Health (NIOSH) for the paper “The Diesel Exhaust in Miners Study: A cohort mortality study with emphasis on lung cancer.”
In July, Neil E. Caporaso, M.D., Chief of the Genetic Epidemiology Branch (GEB), gave the keynote address on “A population perspective on integrative studies” at the American Association for Cancer Research Integrative Molecular Epidemiology workshop in Boston, Massachusetts.
In May, Stephen J. Chanock, M.D., DCEG Director, and Nilanjan Chatterjee, Ph.D., Chief of the Biostatics Branch (BB), assisted in planning the workshop Making Sense of the Sequence: Applications in Population Sciences sponsored by the Epidemiology and Genomics Research Program of NCI’s Division of Cancer Control and Population Sciences in Rockville, Maryland. Dr. Chanock spoke on future directions and offered concluding remarks at the workshop.
In April, Anil K. Chaturvedi, Ph.D., Infections and Immunoepidemiology Branch (IIB), gave a talk on “HPV-associated non-cervical cancers: Burden and prevention potential” at the American Society for Investigative Pathology 2013 Annual Meeting & Centennial Celebration, which took place at Experimental Biology 2013 in Boston, Massachusetts. In May, Dr. Chaturvedi chaired a poster discussion session on “HIV and the lung,” and Debra Silverman, Sc.D., Chief of OEEB, gave a presentation on “The Diesel Exhaust in Miners Study (DEMS)” at the American Thoracic Society 2013 International Conference in Philadelphia, Pennsylvania.
In May, Michael B. Cook, Ph.D., Hormonal and Reproductive Epidemiology Branch (HREB), gave a talk on “Sex disparities in cancer: Incidence, mortality and survival” at the Swedish Medical Center Annual Oncology Symposium titled Women and Cancer: Why Sex Matters” in Seattle, Washington.
In July, two HREB investigators received awards through the Funding to Advance Research on Cancers in Women program from the NCI Office of Science Planning and Assessment and the NIH Office of Research on Women’s Health. Jonine D. Figueroa, Ph.D., M.P.H., and colleagues received funding for their project on “Molecular tumor characteristics of breast cancer in Ghana,” and Nicolas Wentzensen, M.D., Ph.D., M.S., and colleagues received funding for their project on “Biomarker-based classification of cervical precancers: Clinical evaluation in actual practice.”
In July, Neal D. Freedman, Ph.D., M.P.H. (NEB), spoke on “Tobacco research at the NCI Division of Cancer Epidemiology and Genetics” at the U.S. Food and Drug Administration Center for Tobacco Products in Rockville, Maryland, and on “The mutating epidemic: Tobacco and cancer risk in the 21st century” at the NIH National Institute on Aging in Bethesda, Maryland.
In June, Gretchen L. Gierach, Ph.D. (HREB), presented a poster on “The relationship of serum estrogen levels with area and volume measures of mammographic density among women undergoing breast biopsy for clinical indications” at the International Workshop on Breast Densitometry and Breast Cancer Risk Assessment in San Francisco, California. In July, she gave an invited keynote presentation on “Breast density as a risk factor for breast cancer and cancer outcomes” at the Breast Cancer and the Environment Research Program integration meeting, a joint effort by NCI and the National Institute of Environmental Health Sciences, in Rockville, Maryland.
In July, James Goedert, M.D. (IIB), presented a talk on “Anal microbiome in HIV-positive and HIV-negative homosexual men” at the 2nd Wellcome Trust conference on Exploring Human Host-Microbiome Interactions in Health and Disease in Cambridge, United Kingdom.
In June, Allan Hildesheim, Ph.D., Chief of IIB, chaired a session on “Genetics of nasopharyngeal carcinoma” and gave a presentation on “EBV and NPC: From etiologic understanding to clinical application” at the 6th International Symposium on Nasopharyngeal Carcinoma in Istanbul, Turkey. Also at the symposium, Anna Coghill, Ph.D. (IIB), presented an abstract titled “EBV serological and nasopharyngeal carcinoma risk among high risk individuals from multiplex families in Taiwan.”
In June, Shih-Wen (Wenny) Lin, Ph.D., M.P.H. (NEB), spoke on “Networking and managing relationships” at the Stanford University School of Medicine and on “Risk of digestive tract cancers in patients with peptic ulcers in SEER-Medicare” at the Genzyme Corporation in Washington, D.C.
In June, Lindsay M. Morton, Ph.D. (REB), spoke on “The InterLymph NHL Subtypes Project: Methods and preliminary results,” and Nathaniel Rothman, M.D., M.P.H., M.H.S. (OEEB), gave a presentation on “Genome-wide association study (GWAS) of non-Hodgkin lymphoma subtypes: An overview” at the 2013 Annual Meeting of the International Lymphoma Epidemiology (InterLymph) Consortium, held at the University of Dijon, France. Dr. Morton also chaired a working group meeting for the InterLymph NHL Subtypes Project.
In April, Thomas R. O’Brien, M.D., M.P.H. (IIB), gave a presentation titled “A frame-shift variant in the novel IFNL4 gene is associated with impaired HCV clearance” at the 2013 International Liver Congress in Amsterdam, the Netherlands.
In June, several members of BB participated in the 2013 Joint Statistics Conference held by the International Chinese Statistical Association and the International Society for Biopharmaceutical Statistics in Washington, D.C. Ruth M. Pfeiffer, Ph.D., chaired sessions on “Advances in genomics” and “Novel development in risk prediction.” She also gave a presentation “On criteria to assess performance of risk prediction models.” Nilanjan Chatterjee, Ph.D., Chief of BB, presented “Risk prediction based on hidden heritability in genome-wide association studies”; Joshua Sampson, Ph.D., presented “Leveraging local IBD increases the power of case/control GWAS with related individuals”; Jincao Wu, Ph.D., presented “Strategies for developing prediction models from genome-wide association studies”; and Kai Yu, Ph.D., presented “Detecting genetic variants with heterogeneous effects.”
In May, Ruth M. Pfeiffer, Ph.D. (BB) gave a presentation titled “On criteria to assess performance of risk prediction models” at the National Institute of Environmental Health Sciences in Research Triangle Park, North Carolina.
In April, Ludmila Prokunina-Olsson, Ph.D., Laboratory of Translational Genomics, received an award for her poster “Identification and characterization of interferon-λ4 (IFNL4), a new player in human immunity” at the Roche – Nature Medicine Immunology Symposium 2013: Host Immunity to Cancer and Chronic Viral Infections in Buonas, Switzerland. In May, Dr. Prokunina-Olsson spoke on “Finding new genes in the 21st century” at the NIH National Human Genome Research Institute in Bethesda, Maryland, and on “Exploring the role of a novel human interferon IFNL4 in infection, cancer and evolution” at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany. In June, she gave a presentation on “Identification and characterization of interferon-λ4 (IFNL4), a new player in human immunity” at NCI-Frederick; and, in July, she gave a presentation titled “From genetics to translational genomics” at the NCI Genetic Associations and Mechanisms in Oncology Seventh Plenary Meeting in Bethesda, Maryland.
In May, Sharon A. Savage, M.D. (CGB), gave a presentation on “The long and short of telomere length and cancer association studies” at the Cold Spring Harbor Laboratory Telomeres and Telomerase Meeting in New York.
In June, Rachael Stolzenberg-Solomon, Ph.D., M.P.H., R.D. (NEB), gave a talk titled “Diabetes, adiposity, and nutritional exposures that mediate insulin resistance and pancreatic cancer” at the National Institute of Diabetes and Digestive and Kidney Diseases-NCI Workshop on Pancreatitis-Diabetes-Pancreatic Cancer in Bethesda, Maryland. Dr. Stolzenberg-Solomon was also part of the organizing committee for this event.
In June, Philip R. Taylor, M.D., Sc.D. (GEB), gave a presentation on international collaboration in stomach and esophageal cancer research at an NCI Program and Review Extramural Staff Training seminar.
In May, Nicolas Wentzensen, M.D., Ph.D., M.S. (HREB), gave invited talks on “Alternatives to cytology in the context of primary HPV-based screening” and “HPV testing and biomarkers” at the 18th International Congress of Cytology in Paris, France.
In June, Xiaohong Rose Yang, Ph.D., M.P.H. (GEB), spoke on the “Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families with and without CDKN2A mutations” and chaired the session “Genetics and next generation sequencing” at the Melanoma Genetics Consortium (GenoMEL) annual meeting in Philadelphia, Pennsylvania.